NASDAQ: BONBon Natural Life Ltd Stock
$4.32+0.11 (+2.61%)
Updated Apr 25, 2024
BON Price
$4.32
Fair Value Price
N/A
Market Cap
$5.07M
52 Week Low
$3.31
52 Week High
$11.30
P/E
0.86x
P/B
0.14x
P/S
0.13x
PEG
0.01x
Dividend Yield
N/A
Revenue
$29.52M
Earnings
$4.60M
Gross Margin
29.9%
Operating Margin
19.77%
Profit Margin
15.6%
Debt to Equity
0.3
Operating Cash Flow
-$652k
Beta
-0.07
Next Earnings
Apr 26, 2024
Ex-Dividend
N/A
Next Dividend
N/A
BON Overview
Bon Natural Life Limited manufactures functional active ingredients extracted from natural herb plants in China. Offerings include personal care ingredients (plant-extracted fragrance compounds sold to perfume and fragrance manufacturers), natural health supplements (bioactive food ingredient products used as food additives), and nutritional supplements. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BON scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BON ($4.32) is trading below its intrinsic value of $177.71, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BON is good value based on its earnings relative to its share price (0.86x), compared to the US market average (40.97x)
P/E vs Market Valuation
BON is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BON due diligence checks available for Premium users.
Be the first to know about important BON news, forecast changes, insider trades & much more!
BON News
Valuation
BON price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.86x
Industry
8.56x
Market
40.97x
BON is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BON is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BON price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.14x
Industry
2.17x
BON is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BON price to earnings growth (PEG)
For valuing profitable companies with growth potential
BON is good value based... subscribe to Premium to read more.
PEG Value Valuation
BON's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
BON's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BON's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$46.6M
Liabilities
$10.6M
Debt to equity
0.3
BON's short-term assets ($24.18M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BON's short-term assets ($24.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BON's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
BON's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BON vs Food Stocks
Bon Natural Life Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.